Location: Home
  • search
  • go
  • Relate News
  • 12/13/2018Innovent Announces Positive Outcome of Two Clinical Studies for Avasti...
  • 12/13/2018WuXi AppTec Failed to Shine on HKEx Debut
  • 12/12/2018Zai Lab Announces Acceptance of Its NDA for ZEJULA (Niraparib) in Chin...
  • 12/12/2018IntelGenx Partners with Gensco Pharma to Market RIZAPORT in the U.S. a...
  • 12/12/2018Actelion Granted Chinese Approval for PAH Drug Uptravi (Selexipag)
  • 12/12/2018Hong Kong Could Become A Hub for Genetics-Based Drugs Discovery. Just ...
  • 12/12/2018Luye Pharma Files IND for CNS Drug LY03003 in Japan
  • 12/11/2018USFDA Warns Zhejiang Huahai for Failure to Detect Valsartan API Impuri...
  • 12/11/2018Aurobindo Subsidiary and Luoxin Agree to Form Chinese JV
  • 12/11/2018Junshi Biosciences Aims to Raise $414M in Proposed Hong Kong IPO
  • 12/11/2018Lonza to Establish Strategic Biomanufacturing Base in China
  • 12/11/2018HitGen and Mitsubishi Tanabe Pharma Enter Discovery Research Partnersh...
  • 12/11/2018UCB Announces Chinese Approval of Seizure Drug VIMPAT
  • 12/10/2018NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
  • 12/10/2018NH: Chinese OTC Market Growth Steady in MAT Q3 2018, Outpacing Global ...
  • 12/10/2018CBT Pharma and Strata Oncology Tie Up to Accelerate Development of c-M...
  • 12/10/2018WuXi AppTec Expands Site in California for Pharmaceutical R&D ...
  • 12/9/2018Gilead Launches HBV Drug Vemlidy in China
  • 12/7/2018National Centralized Drug Purchase Trial Upsets Pharma Industry with C...
  • 12/7/2018Recent Executive Moves
  • 12/7/2018SAMR Fines Three Violators as It Steps Up Anti-monopoly Crackdown on A...
  • 12/7/2018State Council Approves Patent Amendment Draft and Policies to Boost In...
  • 12/7/2018Brii Bio Announced Partnerships to Jump-start Pipeline with Focus on H...
  • 12/7/2018Oral Insulin Moves Towards Becoming Reality in U.S., China
  • 12/7/2018IFPMA and RDPAC Introduce New Code for Pharmaceutical Marketing Practi...
  • 12/5/2018China Introduces A Range of New Punishments for IP Violations
  • 12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...
  • 12/5/2018PAREXEL and Eli Lilly to Develop Chinese Clinical Research Workforce
  • 12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite
  • 12/5/2018BeiGene Mounts Its Assault On The Ibrutinib Hegemony
  • Page:245/720 Total number of articles:21572: [First][<<] [243] [244] [245] [246] [247] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group